Officials Say Hepatitis C Drug Too Pricey To Give to All Calif. Inmates
California Healthline, Tuesday, October 21, 2014
A new study finds that Gilead's $1,000-per-pill hepatitis C drug could be worth the cost to treat prisoners with the disease, but prison and jail
Michelle